News

The rates of community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) varied dramatically among academic medical centers in California, New York, Illinois and North Carolina, suggesting there is not a uniform change in the “national epidemic” of the “superbug” that has generated extensive public health concern over the past decade, according to a new study.

Green tea and its extracts have been widely touted as potential treatments for cancer, as well as several other diseases. But scientists have struggled to explain how the green tea and its extracts may work to reduce the risk of cancer or to slow the growth of cancer cells.

With the rate of chronic kidney disease on the rise among older Americans, researchers seeking to improve patients’ quality of life studied a group of adults undergoing hemodialysis and found their higher rates of depression and anxiety could be associated with their impaired physical exercise capability and reduced daily physical activity, according a new study published online by the Journal of Renal Nutrition.

Expertscape, a service to help patients find the experts they need to consult on specific medical conditions, recently named Kamyar Kalantar-Zadeh, MD, MPH, PhD, a Los Angeles Biomedical Research Institute (LA BioMed) lead researcher, the world’s No. 1 expert on end-stage kidney, or renal, disease.

Expertscape says it objectively identifies the “most knowledgeable and experienced doctors” by surveying their research publications and determining who has the greatest expertise in a specific condition.

Loren Miller, MD, a Los Angeles Biomedical Research Institute (LA BioMed) lead researcher, is the senior author of a published study that will receive the Association for Professionals in Infection Control and Epidemiology (APIC) Award for Publication Excellence at its annual conference in Anaheim on June 7.

A first-ever World Health Organization assessment of the growing problem calls for rapid changes to avoid the misery and deaths of a potential “post-antibiotic era”
Dangerous antibiotic-resistant bacteria and other pathogens have now emerged in every part of the world and threaten to roll back a century of medical advances. That’s the message from the World Health Organization in its first global report on this growing problem, which draws on drug-resistance data in 114 countries.

From iodine eyedrops that prevent blindness in children to cholesterol testing to early discoveries that led to in vitro fertilization, the Los Angeles Biomedical Research Institute has made innovative scientific breakthroughs with worldwide implications since 1962.

But the renowned research institute hasn’t profited much from the groundbreaking technologies it birthed.

A new study which shows a specific form of garlic that you can buy in any health food store; may control, maybe even reverse heart disease.

Although previous studies have focused on garlic’s effect on cholesterol, this research done by Dr. Matthew Budoff, of LABiomed at Harbor General Hospital in Carson, is the first to look at its direct effect on the hearts arteries.

Budoff told NBC4’s Dr. Bruce Hensel that the reserchers wanted “to see if there is actually benefit to the arteries themselves; if there’s heart disease benefit by taking aged garlic extract.”

MedicalResearch.com Interview with:
Rine Nakanishi, MD, PhD
Los Angeles Biomedical Research Institute

MedicalResearch.com: What are the main findings of the study?

Dr. Nakanishi: With growing evidence that a measurement of the buildup of calcium in
coronary arteries can predict heart disease risk, Los Angeles Biomedical
Research Institute (LA BioMed) researchers found that the process of
“calcium scoring” was also accurate in predicting the chances of dying among
adults with little or no traditional risk factor of heart disease.

With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of “calcium scoring” was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.